Related Experiment Video
Updated: Jun 23, 2026

12:19
Multi-Scale Modification of Metallic Implants With Pore Gradients, Polyelectrolytes and Their Indirect Monitoring In vivo
Published on: July 1, 2013
10.9K
Titanium Biohybrid Middle Ear Prostheses: A Preliminary In Vitro Study
Mario Mosconi1,2, Elena Carlotto3, Laura Caliogna2
1Department of Clinical, Surgical, Diagnostic and Pediatric Sciences, University of Pavia, 27100 Pavia, Italy.
Journal of Functional Biomaterials
|December 22, 2023
Summary
This study explores a novel biohybrid middle ear prosthesis using titanium coated with bone extracellular matrix. Preliminary results show it supports stem cell growth and differentiation, offering a promising alternative for ossiculoplasty.
Area of Science:
- Biomaterials Science
- Regenerative Medicine
- Otolaryngology
Background:
- Ossiculoplasty aims to restore hearing via middle ear prostheses.
- Conventional prostheses face challenges like extrusion.
- Tissue bioengineering offers potential solutions for improved prostheses.
Purpose of the Study:
- To investigate the feasibility of a novel biohybrid middle ear prosthesis.
- To evaluate titanium scaffolds coated with bone extracellular matrix (ECM).
- To assess human adipose-derived mesenchymal stem cells (hASC) behavior on these scaffolds.
Main Methods:
- Cultured hASC on titanium scaffolds coated with bone ECM.
- Analyzed cell adhesion and proliferation using scanning electron microscopy.
- Assessed osteogenic differentiation via immunofluorescence for specific gene markers (Alp, Runx2, Col1a1, Osx, Bglap) and collagen presence.
Main Results:
- Titanium scaffolds supported hASC adhesion and proliferation.
- Demonstrated osteogenic differentiation of hASC on the scaffolds.
- Confirmed ECM formation by hASC, indicating potential for a biohybrid device.
Conclusions:
- Titanium scaffolds coated with bone ECM show potential for supporting hASC.
- This biohybrid approach is promising for developing new ossiculoplasty prostheses.
- Further in vivo studies are recommended to validate these findings for bone transplantation.

